XERS

XERS Operating Expenses

$242.95MTTM · USD

Period ending:

XERS FY Operating ExpensesUSD
XERS FY Operating Expenses2016-12-31: $14.30M2017-12-31: $28.18M2018-12-31: $61.77M2019-12-31: $123.50M2020-12-31: $94.65M2021-12-31: $151.43M2022-12-31: $169.55M2023-12-31: $179.28M2024-12-31: $199.88M2025-12-31: $213.54M$213.54M$0.00
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

XERS operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Xeris Biopharma Holdings Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
213,537,000
199,884,000
179,279,000
169,554,000
151,428,000
94,653,000
123,499,000
61,767,000
28,181,000
14,298,000

Compare operating expenses

All XERS financial metrics · XERS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.